Chung Eun Kyoung, Beeler Cole B, Muloma Eva W, Osterholzer Danielle, Damer Kendra M, Erdman Sharon M
Eun Kyoung Chung, Pharm.D., Ph.D., is Assistant Professor, Clinical Pharmacy/Pharmacotherapy, Department of Pharmacy, Kyung Hee University College of Pharmacy, Seoul, South Korea; at the time of writing she was a graduate student, Department of Pharmacy Practice, Purdue University College of Pharmacy, West Lafeyette, IN. Cole B. Beeler, M.D., is Infectious Diseases Fellow, Indiana University School of Medicine, Indianapolis; at the time of writing he was Chief Internal Medical Resident, Eskenazi Health (formerly Wishard Health Services), Indianapolis. Eva W. Muloma, M.D., is Infectious Diseases Physician, Indiana University Medical Group, and Co-Director, Outpatient Parenteral Antimicrobial Therapy (OPAT) Program, Eskenazi Health. Danielle Osterholzer, M.D., is Infectious Diseases Faculty, Hurley Medical Center, Flint, MI; at the time of writing she was Assistant Clinical Professor of Medicine and Pediatrics, Division of Infectious Diseases, Indiana University School of Medicine, and Section Chief of Infectious Diseases, Eskenazi Health. Kendra M. Damer, Pharm.D., is Associate Professor, Department of Pharmacy Practice, Butler University College of Pharmacy and Health Sciences, Indianapolis; at the time of writing she was Assistant Professor of Pharmacy Practice, Butler University College of Pharmacy and Health Sciences, and Infectious Diseases Clinical Pharmacy Specialist, Eskenazi Health. Sharon M. Erdman, Pharm.D., is Clinical Professor, Department of Pharmacy Practice, Purdue University College of Pharmacy, and Infectious Diseases Clinical Pharmacist and Co-Director, OPAT Program, Eskenazi Health.
Am J Health Syst Pharm. 2016 Jan 1;73(1):e24-33. doi: 10.2146/ajhp150201.
The development and implementation of a pharmacist-managed outpatient parenteral antimicrobial therapy (OPAT) program in a county teaching hospital are described.
A pharmacist-managed OPAT program was developed and implemented at a county teaching hospital to provide consistent evaluation, approval, and monitoring of patients requiring OPAT for the treatment of infection. The developmental and implementation stages of the OPAT program included (1) a needs assessment, (2) the identification of resources necessary for program operation, (3) delineation of general OPAT program operations and activities of individual OPAT clinicians, (4) the development of patient selection criteria, including a plan of care algorithm, and (5) acquisition of administrative support to approve the program. In this program, the OPAT pharmacist plays an integral role in the management and oversight of OPAT patients, working under a collaborative agreement with infectious diseases physicians. The OPAT pharmacist assists with appropriate patient and regimen selection, confirmation of orders on discharge, assuring that laboratory tests for safety surveillance are performed and evaluated, performing routine monitoring for adverse events and line complications, and assuring the removal of the vascular access device upon the completion of OPAT.
The OPAT program provides structured monitoring, patient follow-up, and led to improvements in patient outcome with minimization of treatment and line-related adverse events.
描述在一家县级教学医院开展并实施由药剂师管理的门诊肠外抗菌治疗(OPAT)项目。
在一家县级教学医院开展并实施了由药剂师管理的OPAT项目,以对需要OPAT治疗感染的患者进行持续评估、审批和监测。OPAT项目的开展和实施阶段包括:(1)需求评估;(2)确定项目运作所需资源;(3)划定OPAT项目总体运作及各OPAT临床医生的活动;(4)制定患者选择标准,包括护理计划算法;(5)获得行政支持以批准该项目。在该项目中,OPAT药剂师在OPAT患者的管理和监督中发挥不可或缺的作用,根据与传染病医生的合作协议开展工作。OPAT药剂师协助进行合适的患者和治疗方案选择、出院医嘱确认、确保进行并评估安全监测的实验室检查、对不良事件和管路并发症进行常规监测,以及在OPAT结束后确保移除血管通路装置。
OPAT项目提供了结构化监测、患者随访,并改善了患者结局,同时将治疗及与管路相关的不良事件降至最低。